A single-institution experience of pneumonitis in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

被引：0
|
作者：
Masur, Jack
Ali, Soham
Fortune, Kathryn
Bueno, Juliana
Battey, Thomas
Mullapudi, Abhishek
Goudarzi, Ariaz
Patel, Hitesh
Sturek, Jeffrey
Devitt, Michael Edward
Skelton, William Paul
Dreicer, Robert
Viscuse, Paul Vincent
机构：
[1] Univ Virginia, Div Hematol Oncol, Charlottesville, VA USA
[2] Univ Virginia, Dept Internal Med, Charlottesville, VA USA
[3] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA
[4] Univ Virginia, Sch Med, Charlottesville, VA USA
[5] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors
    Negishi, Takahito
    Nakagawa, Tohru
    Nishiyama, Naotaka
    Kitamura, Hiroshi
    Okajima, Eijiro
    Furubayashi, Nobuki
    Hori, Yoshifumi
    Kuroiwa, Kentarou
    Son, Yuhyon
    Seki, Narihito
    Tomoda, Toshihisa
    Nakamura, Motonobu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (12) : 1430 - 1435
  • [22] Comparison of outcomes between patients of African and European descent with metastatic renal cell carcinoma receiving immune checkpoint inhibitors.
    Kaur, Jasmeet
    Hasler, Jill S.
    Handorf, Elizabeth A.
    Zibelman, Matthew R.
    Geynisman, Daniel M.
    Plimack, Elizabeth R.
    Ghatalia, Pooja
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 369 - 369
  • [23] Outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) and sarcomatoid dedifferentiation (sRCC) after treatment with immune checkpoint inhibitors (ICI): A single-institution retrospective study.
    Ross, Jeremy Aaron
    McCormick, Barrett Z.
    Gao, Jianjun
    Msaouel, Pavlos
    Campbell, Matthew T.
    Zurita, Amado J.
    Shah, Amishi Yogesh
    Jonasch, Eric
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Sharma, Padmanee
    Tannir, Nizar M.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [24] Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Chehade, Razane El Hajj
    Semaan, Karl
    Saliby, Renee Maria
    Saad, Eddy
    Nawfal, Rashad
    Machaalani, Marc
    Eid, Marc
    Yekeduz, Emre
    Steiner, Clara
    Sun, Maxine
    Kaymakcalan, Marina
    Choueiri, Toni K.
    ONCOLOGIST, 2024, 29
  • [25] Hyperprogressive disease in patients with metastatic genitourinary tumors treated with immune checkpoint inhibitors.
    Suarez, Cristina
    Morales-Barrera, Rafael
    Garcia-Ruiz, Alonso
    Gonzalez, Macarena
    Ligero, Marta
    Valverde, Claudia
    Serrano, Cesar
    Mateo, Joaquin
    Perez-Lopez, Raquel
    Carles, Joan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [26] A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors
    Shalata, Walid
    Weissmann, Sarah
    Gabay, Sapir Itzhaki
    Sheva, Kim
    Abu Saleh, Omar
    Abu Jama, Ashraf
    Yakobson, Alexander
    Rouvinov, Keren
    CANCERS, 2022, 14 (21)
  • [27] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Yuki Nemoto
    Hiroki Ishihara
    Kazutaka Nakamura
    Hidekazu Tachibana
    Hironori Fukuda
    Kazuhiko Yoshida
    Hirohito Kobayashi
    Junpei Iizuka
    Hiroaki Shimmura
    Yasunobu Hashimoto
    Kazunari Tanabe
    Tsunenori Kondo
    Toshio Takagi
    International Urology and Nephrology, 2022, 54 : 47 - 54
  • [28] Efficacy and safety of immune checkpoint inhibitors in elderly patients with metastatic renal cell carcinoma
    Nemoto, Yuki
    Ishihara, Hiroki
    Nakamura, Kazutaka
    Tachibana, Hidekazu
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Kobayashi, Hirohito
    Iizuka, Junpei
    Shimmura, Hiroaki
    Hashimoto, Yasunobu
    Tanabe, Kazunari
    Kondo, Tsunenori
    Takagi, Toshio
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (01) : 47 - 54
  • [29] Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors
    Chahoud, Jad
    Msaouel, Pavlos
    Ross, Jeremy A.
    McCormick, Barrett Z.
    Bathala, Tharakeswara K.
    Gao, Jianjun
    Horn, Robert
    Xiao, Lianchun
    Sircar, Kanishka
    Campbell, Matthew T.
    Shah, Amishi Y.
    Goswami, Sangeeta
    Zurita, Amado J.
    Jonasch, Eric
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Sharma, Padmanee
    Tannir, Nizar M.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (02) : 134.e9 - 134.e16
  • [30] Neurotoxicity in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis
    Santomasso, Bianca
    Malani, Rachna
    Haggiagi, Aya
    Holder, Jenessa
    Shames, Yelena
    Briggs, Samuel
    Callahan, Margaret
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345